Published guidance, NICE advice and quality standards | Guidance

Showing 141 to 150 of 302

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Transurethral laser ablation for recurrent non-muscle-invasive bladder cancer	IPG656	24 July 2019	24 July 2019
Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer	TA584	5 June 2019	5 June 2019
Enzalutamide for hormone-relapsed non-metastatic prostate cancer	TA580	15 May 2019	15 May 2019
ADXBLADDER for detecting bladder cancer	MIB180	12 April 2019	12 April 2019
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib	TA571	20 March 2019	20 March 2019
Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer	TA569	20 March 2019	20 March 2019
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer	TA563	27 February 2019	27 February 2019
Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal)	TA560	20 February 2019	20 February 2019
Axumin for functional imaging of prostate cancer recurrence	MIB172	8 February 2019	8 February 2019
Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer	IPG638	30 January 2019	30 January 2019